Evidence map›Paper›PMID 40624490›Full record

ArticleJournal of nanobiotechnology2025

Synergizing sono-piezo with exosome suppression using doping-engineered hydroxyapatite for potentiated tumor treatment through immunoactivation.

Xinran Qu, Qin Fan, Yingying Liu, Jinqiao Zhang, Boyu Yuan, Xianzhou Cai, Luli Ji, Rulin Zhuang, Ziliang Dong

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinran Qu *Science and Technology Innovation Center, Shandong First Medical University& Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China.
Qin Fan *State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing, Jiangsu, 210000, P. R. China.
Yingying LiuScience and Technology Innovation Center, Shandong First Medical University& Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China. liuyingying@sdfmu.edu.cn.
Jinqiao ZhangScience and Technology Innovation Center, Shandong First Medical University& Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China.
Boyu YuanScience and Technology Innovation Center, Shandong First Medical University& Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China.
Xianzhou CaiScience and Technology Innovation Center, Shandong First Medical University& Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China.
Luli JiDongzhimen Hospital, Affiliated to Beijing University of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100007, P. R. China.
Rulin ZhuangDepartment of Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, P. R. China. rulinzhuang@njmu.edu.cn.
Ziliang DongScience and Technology Innovation Center, Shandong First Medical University& Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P. R. China. Zldong0220@163.com.

Funding

National Natural Science Foundation of China 22307057National Natural Science Foundation of China 52302350Natural Science Foundation of Jiangsu Province BK20220401Natural Science Foundation of Shandong Province ZR2021QE112Natural Science Foundation of Shandong Province ZR2024QC370Shandong Provincial Taishan Scholars Program tsqn202312237
6 · The paper itself

Abstract

Piezoelectric nanomaterials that generate reactive oxygen species (ROS) through piezoelectric polarization under mechanical stimulation have emerged as a promising cancer therapy platform. However, their potential is limited by poor piezoresponse, low catalytic efficiency, and the exacerbation of immunosuppression due to ROS-induced release of tumor-derived exosomes. In this study, we employed a doping-engineered strategy by incorporating manganese ions (Mn

Indexed as

DurapatiteExosomesNeoplasmsAniline CompoundsAnimalsBenzylidene CompoundsCell Line, TumorHumansManganeseMiceMice, Inbred BALB CNanocompositesReactive Oxygen SpeciesAniline CompoundsBenzylidene CompoundsDurapatiteGW 4869ManganeseReactive Oxygen SpeciesDoping-engineeredExosome inhibitionImmunoactivationPiezoelectric catalysisTumor treatment

Identifiers

PMID40624490
PMCPMC12235841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.